The oncology precision medicine industry is rapidly evolving as cutting-edge technologies increasingly enable personalized cancer treatments tailored to patients’ genetic profiles. Fueled by innovations in genomics and bioinformatics, this sector is witnessing significant advances in targeted therapies, driving transformative outcomes in oncology care and reshaping treatment paradigms...

The oncology precision medicine industry is experiencing transformative growth driven by advancements in genomic profiling and targeted therapies. This sector is redefining cancer treatment paradigms through personalized approaches, substantially enhancing patient outcomes. The evolving landscape is marked by increased investment in precision diagnostics and biomarker-driven drug development,...